Cargando…
Everolimus in acute kidney injury in a patient with breast cancer: a case report
INTRODUCTION: Everolimus, a mammalian target of Rapamycin inhibitor, has recently been approved for the treatment of metastatic estrogen receptor-positive breast cancer, in combination with exemestane at a daily dose of 10mg. In the literature, few cases of acute kidney injury have been reported rel...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4364691/ https://www.ncbi.nlm.nih.gov/pubmed/25420955 http://dx.doi.org/10.1186/1752-1947-8-386 |